Showing results (131-140 of 741) with videos related to
Sort By:
Pageof 75
Seminars in Oncology|January 10, 2003
Myeloma and the newly diagnosed patient: a focus on treatment and managementS Vincent Rajkumar, Robert A Kyle, Morie A GertzMayo Clinic Proceedings|May 6, 2017
Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and ManagementHafsa M Chaudhry, Michelle L Mauermann, S Vincent RajkumarBlood|February 23, 2012
Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristicsAlexandra J Greenberg, S Vincent Rajkumar, Celine M VachonAmerican Journal of Hematology|September 28, 2010
Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugsAngela Dispenzieri, David Dingli, Shaji K Kumar, et al.Blood Advances|March 22, 2022
Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening methodCeline M Vachon, Josiah Murray, Cristine Allmer, et al.Leukemia & Lymphoma|June 9, 2017
Diagnosis and management of smoldering multiple myeloma: the razor's edge between clonality and cancerEli Muchtar, Shaji K Kumar, Hila Magen, et al.Blood Cancer Journal|January 11, 2023
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myelomaWee-Joo Chng, Sagar Lonial, Gareth J Morgan, et al.Blood|November 3, 2007
Improved survival in multiple myeloma and the impact of novel therapiesShaji K Kumar, S Vincent Rajkumar, Angela Dispenzieri, et al.Leukemia|January 31, 2019
Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenanceShaji K Kumar, Jesus G Berdeja, Ruben Niesvizky, et al.Blood Cancer Journal|September 5, 2022
Smoldering multiple myeloma current treatment algorithmsS Vincent Rajkumar, Shaji Kumar, Sagar Lonial, et al.Pageof 75